ActualitésAssisté par IA

Marksans Pharma’s Goa Facility Receives EIR, Inspection Closed with VAI Classification

Marksans Pharma's Goa facility receives EIR from USFDA, inspection classified as VAI.

Par Mrudula Kulkarni

Rédacteur en chef - Pharma Now

21 août 2024Updated Jun 26, 2025 · 2 min de lecture

Partager Ajouter comme source préférée

Marksans Pharma’s Goa Facility Receives EIR, Inspection Closed with VAI Classification — https://www.marksanspharma.com/

Journalisme assisté par IA

Reviewed by Mrudula Kulkarni, Rédacteur en chef - Pharma Now

For its production site in Verna, Goa, Marksans Pharma said that the USFDA had issued an Establishment Inspection Report (EIR), which it has now successfully closed. According to USFDA findings, this facility's inspection categorisation is Voluntary Action Indicated (VAI).

SujetsActualités

Written by

Mrudula Kulkarni

Rédacteur en chef - Pharma Now

My international experience as a researcher in Taiwan for three years has equipped me with a global perspective, enabling me to create content that resonates with an international audience.